Cargando…

Clinical Performance Assessment of a New Active Osseointegrated Implant System in Mixed Hearing Loss: Results From a Prospective Clinical Investigation

Evaluation of a new active osseointegrated bone-conduction hearing implant in moderate to severe mixed-hearing loss. STUDY DESIGN: Prospective observational study of a series of cases. SETTING: Tertial referral center. PATIENTS: Twenty patients with moderate mixed-hearing loss were evaluated (10 Coc...

Descripción completa

Detalles Bibliográficos
Autores principales: Pla-Gil, Ignacio, Redó, María Aragonés, Pérez-Carbonell, Tomàs, Martínez-Beneyto, Paz, Alborch, Miguel Orts, Ventura, Antonio Morant, Monteagudo, Emilia Latorre, Ribas, Ignacia Pitarch, Algarra, Jaime Marco
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Lippincott Williams & Wilkins 2021
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8279898/
https://www.ncbi.nlm.nih.gov/pubmed/33710155
http://dx.doi.org/10.1097/MAO.0000000000003116
_version_ 1783722538744938496
author Pla-Gil, Ignacio
Redó, María Aragonés
Pérez-Carbonell, Tomàs
Martínez-Beneyto, Paz
Alborch, Miguel Orts
Ventura, Antonio Morant
Monteagudo, Emilia Latorre
Ribas, Ignacia Pitarch
Algarra, Jaime Marco
author_facet Pla-Gil, Ignacio
Redó, María Aragonés
Pérez-Carbonell, Tomàs
Martínez-Beneyto, Paz
Alborch, Miguel Orts
Ventura, Antonio Morant
Monteagudo, Emilia Latorre
Ribas, Ignacia Pitarch
Algarra, Jaime Marco
author_sort Pla-Gil, Ignacio
collection PubMed
description Evaluation of a new active osseointegrated bone-conduction hearing implant in moderate to severe mixed-hearing loss. STUDY DESIGN: Prospective observational study of a series of cases. SETTING: Tertial referral center. PATIENTS: Twenty patients with moderate mixed-hearing loss were evaluated (10 Cochlear Osia group and 10 Baha 5 Power Connect -control group). INTERVENTION: Rehabilitative. MAIN OUTCOME MEASURES: Hearing performance in quiet and in noise and quality-of-life were evaluated. RESULTS: Improvements in audibility, speech-understanding, speech-recognition, and quality-of-sound in noise and quiet were found for the Osia System compared with preoperative unaided hearing and performance was similar to that obtained with Baha 5 Power Connect. CONCLUSIONS: The new active transcutaneous bone conduction system provided a tonal improvement in free-field at middle and high frequencies. The performance in speech recognition in quiet and in noise was similar to control group outcomes.
format Online
Article
Text
id pubmed-8279898
institution National Center for Biotechnology Information
language English
publishDate 2021
publisher Lippincott Williams & Wilkins
record_format MEDLINE/PubMed
spelling pubmed-82798982021-07-15 Clinical Performance Assessment of a New Active Osseointegrated Implant System in Mixed Hearing Loss: Results From a Prospective Clinical Investigation Pla-Gil, Ignacio Redó, María Aragonés Pérez-Carbonell, Tomàs Martínez-Beneyto, Paz Alborch, Miguel Orts Ventura, Antonio Morant Monteagudo, Emilia Latorre Ribas, Ignacia Pitarch Algarra, Jaime Marco Otol Neurotol Prosthetic Devices Evaluation of a new active osseointegrated bone-conduction hearing implant in moderate to severe mixed-hearing loss. STUDY DESIGN: Prospective observational study of a series of cases. SETTING: Tertial referral center. PATIENTS: Twenty patients with moderate mixed-hearing loss were evaluated (10 Cochlear Osia group and 10 Baha 5 Power Connect -control group). INTERVENTION: Rehabilitative. MAIN OUTCOME MEASURES: Hearing performance in quiet and in noise and quality-of-life were evaluated. RESULTS: Improvements in audibility, speech-understanding, speech-recognition, and quality-of-sound in noise and quiet were found for the Osia System compared with preoperative unaided hearing and performance was similar to that obtained with Baha 5 Power Connect. CONCLUSIONS: The new active transcutaneous bone conduction system provided a tonal improvement in free-field at middle and high frequencies. The performance in speech recognition in quiet and in noise was similar to control group outcomes. Lippincott Williams & Wilkins 2021-08 2021-03-11 /pmc/articles/PMC8279898/ /pubmed/33710155 http://dx.doi.org/10.1097/MAO.0000000000003116 Text en Copyright © 2021 The Author(s). Published by Wolters Kluwer Health, Inc. on behalf of Otology & Neurotology, Inc. https://creativecommons.org/licenses/by-nc-nd/4.0/This is an open access article distributed under the terms of the Creative Commons Attribution-Non Commercial-No Derivatives License 4.0 (CCBY-NC-ND), where it is permissible to download and share the work provided it is properly cited. The work cannot be changed in any way or used commercially without permission from the journal. http://creativecommons.org/licenses/by-nc-nd/4.0 (https://creativecommons.org/licenses/by-nc-nd/4.0/)
spellingShingle Prosthetic Devices
Pla-Gil, Ignacio
Redó, María Aragonés
Pérez-Carbonell, Tomàs
Martínez-Beneyto, Paz
Alborch, Miguel Orts
Ventura, Antonio Morant
Monteagudo, Emilia Latorre
Ribas, Ignacia Pitarch
Algarra, Jaime Marco
Clinical Performance Assessment of a New Active Osseointegrated Implant System in Mixed Hearing Loss: Results From a Prospective Clinical Investigation
title Clinical Performance Assessment of a New Active Osseointegrated Implant System in Mixed Hearing Loss: Results From a Prospective Clinical Investigation
title_full Clinical Performance Assessment of a New Active Osseointegrated Implant System in Mixed Hearing Loss: Results From a Prospective Clinical Investigation
title_fullStr Clinical Performance Assessment of a New Active Osseointegrated Implant System in Mixed Hearing Loss: Results From a Prospective Clinical Investigation
title_full_unstemmed Clinical Performance Assessment of a New Active Osseointegrated Implant System in Mixed Hearing Loss: Results From a Prospective Clinical Investigation
title_short Clinical Performance Assessment of a New Active Osseointegrated Implant System in Mixed Hearing Loss: Results From a Prospective Clinical Investigation
title_sort clinical performance assessment of a new active osseointegrated implant system in mixed hearing loss: results from a prospective clinical investigation
topic Prosthetic Devices
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8279898/
https://www.ncbi.nlm.nih.gov/pubmed/33710155
http://dx.doi.org/10.1097/MAO.0000000000003116
work_keys_str_mv AT plagilignacio clinicalperformanceassessmentofanewactiveosseointegratedimplantsysteminmixedhearinglossresultsfromaprospectiveclinicalinvestigation
AT redomariaaragones clinicalperformanceassessmentofanewactiveosseointegratedimplantsysteminmixedhearinglossresultsfromaprospectiveclinicalinvestigation
AT perezcarbonelltomas clinicalperformanceassessmentofanewactiveosseointegratedimplantsysteminmixedhearinglossresultsfromaprospectiveclinicalinvestigation
AT martinezbeneytopaz clinicalperformanceassessmentofanewactiveosseointegratedimplantsysteminmixedhearinglossresultsfromaprospectiveclinicalinvestigation
AT alborchmiguelorts clinicalperformanceassessmentofanewactiveosseointegratedimplantsysteminmixedhearinglossresultsfromaprospectiveclinicalinvestigation
AT venturaantoniomorant clinicalperformanceassessmentofanewactiveosseointegratedimplantsysteminmixedhearinglossresultsfromaprospectiveclinicalinvestigation
AT monteagudoemilialatorre clinicalperformanceassessmentofanewactiveosseointegratedimplantsysteminmixedhearinglossresultsfromaprospectiveclinicalinvestigation
AT ribasignaciapitarch clinicalperformanceassessmentofanewactiveosseointegratedimplantsysteminmixedhearinglossresultsfromaprospectiveclinicalinvestigation
AT algarrajaimemarco clinicalperformanceassessmentofanewactiveosseointegratedimplantsysteminmixedhearinglossresultsfromaprospectiveclinicalinvestigation